| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Louis Jeantet Skin Cancer Laboratory, Department of Pathology and Immunology, Geneva University Medical Center, Geneva, Switzerland;
Institut Suisse de Recherches Experimentales sur le Cancer, Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland; and
Department of Dermatology, Geneva University Hospital, Geneva, Switzerland
Dendritic cells (DC) are potent inducers of immune responses. DC have been shown to infiltrate tumors, but very little is known about the functional status of these naturally occurring tumor-infiltrating DC (TIDC). In this study, the status and function of TIDC from several types of mouse melanoma were investigated in detail. CD11c+/MHC II+ cells, consistent with a DC phenotype, were found in all of transplantable or spontaneous melanomas studied. These TIDC were predominantly myeloid (CD11c+/CD8
–/B220–) in nature with small numbers of plasmacytoid (CD11c+/B220+). TIDC had an intermediate maturation phenotype with some expression of costimulatory molecules and the capacity to take up particles. Upon culture overnight ex vivo, the TIDC markedly up-regulated the expression of costimulatory molecules and also increased IL-12 production. Importantly, such ex vivo-matured TIDC pulsed with OVA were able to migrate to lymph nodes, to activate naive OVA-specific CD4+ and CD8+ T cells, and to confer protection against a challenge with OVA-expressing tumor cells. In conclusion, melanomas are infiltrated by functional DC that can act as fully competent APC. These APC have the potential to be manipulated and may therefore represent a promising target for cancer immunotherapy.
This article has been cited by other articles:
|
|
 |
|
  M. D. Sharma, D.-Y. Hou, Y. Liu, P. A. Koni, R. Metz, P. Chandler, A. L. Mellor, Y. He, and D. H. Munn Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes Blood, June 11, 2009; 113(24): 6102 - 6111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Gerner and M. F. Mescher Antigen Processing and MHC-II Presentation by Dermal and Tumor-Infiltrating Dendritic Cells J. Immunol., March 1, 2009; 182(5): 2726 - 2737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sakai, M. Honda, H. Fujinaga, I. Tatsumi, E. Mizukoshi, Y. Nakamoto, and S. Kaneko Common Transcriptional Signature of Tumor-Infiltrating Mononuclear Inflammatory Cells and Peripheral Blood Mononuclear Cells in Hepatocellular Carcinoma Patients Cancer Res., December 15, 2008; 68(24): 10267 - 10279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-m. Zhao, Y.-j. Wen, Q. Li, Y.-s. Wang, H.-b. Wu, J.-r. Xu, X.-c. Chen, Y. Wu, L.-y. Fan, H.-s. Yang, et al. A promising cancer gene therapy agent based on the matrix protein of vesicular stomatitis virus FASEB J, December 1, 2008; 22(12): 4272 - 4280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Schuler, E. Contassot, M. Irla, S. Hugues, O. Preynat-Seauve, F. Beermann, A. Donda, L.E. French, and B. Huard Direct Presentation of a Melanocyte-Associated Antigen in Peripheral Lymph Nodes Induces Cytotoxic CD8+ T Cells Cancer Res., October 15, 2008; 68(20): 8410 - 8418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Preynat-Seauve, E. Contassot, P. Schuler, V. Piguet, L. E. French, and B. Huard Extralymphatic Tumors Prepare Draining Lymph Nodes to Invasion via a T-Cell Cross-Tolerance Process Cancer Res., May 15, 2007; 67(10): 5009 - 5016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Perrot, D. Blanchard, N. Freymond, S. Isaac, B. Guibert, Y. Pacheco, and S. Lebecque Dendritic Cells Infiltrating Human Non-Small Cell Lung Cancer Are Blocked at Immature Stage J. Immunol., March 1, 2007; 178(5): 2763 - 2769. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
